Search Count: 17
 |
Il-23R Minibinder - 23R-B04Dslf02Ib
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2024-07-10 Classification: DE NOVO PROTEIN Ligands: PG6, SO4, PG5 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2024-07-10
Ligands: PG6, SO4, PG5
 |
Alpha-Latrocrustotoxin Monomer
Organism: Latrodectus tredecimguttatus
Method: ELECTRON MICROSCOPY Release Date: 2021-12-08 Classification: TOXIN |
Organism: Latrodectus tredecimguttatus
Method: ELECTRON MICROSCOPY
Release Date: 2021-12-08
 |
Delta-Latroinsectotoxin Dimer
Organism: Latrodectus tredecimguttatus
Method: ELECTRON MICROSCOPY Release Date: 2021-12-08 Classification: TOXIN |
Organism: Latrodectus tredecimguttatus
Method: ELECTRON MICROSCOPY
Release Date: 2021-12-08
 |
H5.3 Fab Structure
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2013-08-21 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-08-21
 |
Crystal Structure Of Human Fxr In Complex With 4-({(2S)-2-[2-(4-Chlorophenyl)-5,6-Difluoro-1H-Benzimidazol-1-Yl]-2-Cyclohexylacetyl}Amino)-3-Methylbenzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2011-01-19 Classification: HORMONE RECEPTOR Ligands: OLF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-01-19
Ligands: OLF
 |
Crystal Structure Of Human Fxr In Complex With (2S)-2-[2-(4-Chlorophenyl)-5,6-Difluoro-1H-Benzimidazol-1-Yl]-2-Cyclohexyl-N-(2-Methylphenyl)Ethanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2011-01-19 Classification: HORMONE RECEPTOR Ligands: OMK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-01-19
Ligands: OMK
 |
Crystal Structure Of Human Fxr In Complex With 4-({(2S)-2-[2-(4-Chlorophenyl)-5,6-Difluoro-1H-Benzimidazol-1-Yl]-2-Cyclohexylacetyl}Amino)-3-Fluorobenzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2011-01-19 Classification: HORMONE RECEPTOR Ligands: OMM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-01-19
Ligands: OMM
 |
Crystal Structure Of Human Fxr In Complex With 4-({(2S)-2-[2-(4-Chlorophenyl)-5,6-Difluoro-1H-Benzimidazol-1-Yl]-2-Cyclohexylacetyl}Amino)Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2011-01-19 Classification: HORMONE RECEPTOR Ligands: OOF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-01-19
Ligands: OOF
 |
Crystal Structure Of Human Fxr In Complex With 4-({(2S)-2-[2-(4-Chlorophenyl)-5,6-Difluoro-1H-Benzimidazol-1-Yl]-2-Cyclohexylacetyl}Amino)-3,5-Difluorobenzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2011-01-19 Classification: HORMONE RECEPTOR Ligands: OOK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-01-19
Ligands: OOK
 |
Crystal Structure Of Human Fxr In Complex With 2-(4-Chlorophenyl)-1-[(1S)-1-Cyclohexyl-2-(Cyclohexylamino)-2-Oxoethyl]-1H-Benzimidazole-6-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2010-12-29 Classification: HORMONE RECEPTOR Ligands: OKH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2010-12-29
Ligands: OKH
 |
Crystal Structure Of Human Fxr In Complex With (2S)-2-[2-(4-Chlorophenyl)-1H-Benzimidazol-1-Yl]-N,2-Dicyclohexylethanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2010-12-29 Classification: HORMONE RECEPTOR Ligands: OKI |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2010-12-29
Ligands: OKI
 |
Design And Biological Evaluation Of Novel, Balanced Dual Ppara/G Agonists
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2009-10-20 Classification: TRANSCRIPTION Ligands: CTM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-10-20
Ligands: CTM
 |
Design And Biological Evaluation Of Novel, Balanced Dual Ppara/G Agonists
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2009-10-20 Classification: TRANSCRIPTION Ligands: CTM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-10-20
Ligands: CTM
 |
Aleglitazar, A New, Potent, And Balanced Ppar Alpha/Gamma Agonist For The Treatment Of Type Ii Diabetes
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2009-06-02 Classification: TRANSCRIPTION/TRANSFERASE Ligands: RO7 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-06-02
Ligands: RO7
 |
Aleglitaar. A New. Potent, And Balanced Dual Ppara/G Agonist For The Treatment Of Type Ii Diabetes
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2009-06-02 Classification: TRANSCRIPTION/TRANSFERASE Ligands: RO7 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-06-02
Ligands: RO7
 |
Structural Basis For The Substrate Specificity Of The Ferul Domain Of The Cellulosomal Xylanase Z From C. Thermocellum
Organism: Clostridium thermocellum
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2002-03-27 Classification: HYDROLASE Ligands: FER |
Organism: Clostridium thermocellum
Method: X-RAY DIFFRACTION
Release Date: 2002-03-27
Ligands: FER
 |
Structural Basis For The Substrate Specificity Of The Feruloyl Esterase Domain Of The Cellulosomal Xylanase Z Of Clostridium Thermocellum
Organism: Clostridium thermocellum
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2001-10-31 Classification: HYDROLASE Ligands: PT |
Organism: Clostridium thermocellum
Method: X-RAY DIFFRACTION
Release Date: 2001-10-31
Ligands: PT